Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol Chaperone Therapy for Neuronopathic Gaucher Disease
jRCTs061180090Completed
- Sponsor
- Sanofi
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ambroxol in Gaucher disease (GD), sponsored by Sanofi. Primary endpoint: Safety. Started Mar 2010; status: completed.
02
Drugs
ambroxol
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on jRCTs061180090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180090.